A&G Pharmaceutical, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.agpharma.com
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Phase 1
Recruiting
- Conditions
- Hormone-Resistant Breast CancerNon Small Cell Lung CancerTriple Negative Breast CancerMesothelioma
- Interventions
- Drug: AG-01 Compound
- First Posted Date
- 2022-11-28
- Last Posted Date
- 2022-11-28
- Lead Sponsor
- A&G Pharmaceutical Inc.
- Target Recruit Count
- 77
- Registration Number
- NCT05627960
- Locations
- 🇺🇸
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath